Cervical Cancer Vaccine

In addition to the Pap smear, one of the many other prevention strategies known is through vaccines.

Recent research data, conference IPV (International Papilloma Virus) to-24 in Beijing showed that cervical cancer vaccines already exist and circulate in Indonesia is currently effective, and can provide protection for women up to age 45. This vaccine prevents 91% persistent infection, mild abnormalities, pre-cancerous lesions, and genital warts in the area caused by the HPV virus specific compared to the placebo group.

Efforts at prevention is vaccination and cervical cancer early detection is very important because it can help reduce the prevalence of cervical cancer.

According to data from International Agency for Research on Cancer, HPV has been shown to be associated with more than 95% of cervical cancer cases.

The virus is spread through sexual contact and skin-to-skin contact in the genital area, so that every sexually active woman is at risk.

In addition to cervical cancer, HPV virus also causes other problems such as:

Cervical dysplasia (abnormal cervical cell growth)
Genital warts (warts on the genitals)
Vulvar cancer, and so on
Cervical cancer vaccine proves effective against pre-cancerous lesions associated with HPV types 16 and 18 all (two types of main causes 70% of cervical cancer cases).